Xu Liangdong, Zhou Hangcheng, Wang Gaoxiang, Huang Zhining, Xiong Ran, Sun Xiaohui, Wu Mingsheng, Li Tian, Xie Mingran
Department of Thoracic Surgery, Affiliated Provincial Hospital of Anhui Medical University, Hefei, China.
Department of Thoracic Surgery, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Front Oncol. 2022 Aug 10;12:954317. doi: 10.3389/fonc.2022.954317. eCollection 2022.
This study aimed to explore the value of micropapillary histological subtypes in predicting the specific surgical specificity and lymph node metastasis prognosis of early lung adenocarcinoma.
A total of 390 patients with lung adenocarcinoma were included who underwent surgery in the Department of Thoracic Surgery of the Affiliated Provincial Hospital of Anhui Medical University from January 2016 to December 2017. The data were analysed with SPSS 26.0 statistical software, and the clinicopathological data of the two groups were compared with the chi-square test. The survival rate was calculated by the Kaplan-Meier method, and the difference in survival rate between groups was analysed by the log-rank test. Multivariate survival analysis was performed using the Cox model.
Univariate analysis of the clinicopathological data of the patients showed that the micropapillary histological subtype was significantly associated with the survival rate of patients (p=0.007). The clinicopathological data of the patients were substituted into the Cox model for multivariate analysis, and the results showed that the micropapillary histological subtype was an independent prognostic factor affecting the survival rate of the patients (p=0.009).The average survival time of Group A (micronipple composition > 5%) was 66.7 months; the 1-year, 3-year, and 5-year survival rates were 98.8%, 93.0%, and 80.9%, respectively.The survival of the lobectomy group was better than that of the sublobectomy group and the survival of patients with systematic dissection was better than that of patients with limited lymph node dissection. The average survival time of Group B (micronipple composition ≤ 5%) was 70.5 months; the 1-year, 3-year, and 5-year survival rates were 99.3%, 95.4%, and 90.6%, respectively. There was no difference in the survival rate between the lobectomy group and sublobectomy group, and there was also no difference in survival between systematic lymph node dissection and limited lymph node dissection, The survival rate of Group B was significantly better than that of Group A.
The micropapillary histological component is an independent risk factor after surgery in patients with ≤2 cm lung adenocarcinoma. When the proportion of micropapillary components is different, the prognosis of patients is different when different surgical methods and lymph node dissections are performed. Lobectomy and systematic lymph node dissection are recommended for patients with a micropapillary histological composition >5%; sublobar resection and limited lymph node dissection are recommended for patients with a micropapillary histological composition ≤5%.
本研究旨在探讨微乳头组织学亚型在预测早期肺腺癌特定手术特异性及淋巴结转移预后方面的价值。
纳入2016年1月至2017年12月在安徽医科大学附属省立医院胸外科接受手术的390例肺腺癌患者。采用SPSS 26.0统计软件进行数据分析,两组临床病理资料比较采用卡方检验。采用Kaplan-Meier法计算生存率,组间生存率差异采用log-rank检验分析。使用Cox模型进行多因素生存分析。
对患者临床病理资料进行单因素分析显示,微乳头组织学亚型与患者生存率显著相关(p=0.007)。将患者临床病理资料代入Cox模型进行多因素分析,结果显示微乳头组织学亚型是影响患者生存率的独立预后因素(p=0.009)。A组(微乳头成分>5%)平均生存时间为66.7个月;1年、3年和5年生存率分别为98.8%、93.0%和80.9%。肺叶切除组生存率优于肺段切除组,系统性清扫患者生存率优于局限性淋巴结清扫患者。B组(微乳头成分≤5%)平均生存时间为70.5个月;1年、3年和5年生存率分别为99.3%、95.4%和90.6%。肺叶切除组与肺段切除组生存率无差异,系统性淋巴结清扫与局限性淋巴结清扫生存率也无差异,B组生存率显著优于A组。
微乳头组织学成分是≤2 cm肺腺癌患者术后的独立危险因素。当微乳头成分比例不同时,采用不同手术方式和淋巴结清扫时患者预后不同。微乳头组织学成分>5%的患者建议行肺叶切除及系统性淋巴结清扫;微乳头组织学成分≤5%的患者建议行肺段切除及局限性淋巴结清扫。